Tag: Synthorx
US: Sanofi buys Synthorx for $2.5B
Sanofi has agreed to buy cancer biotech company Synthorx for $2.5 billion, the first big move by new Chief Executive Paul Hudson to reinvigorate...
Privacy Overview
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.